A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response ...

A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response critical for their elimination.

Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop their ...

Panelists discuss the role of molecular testing in metastatic non–-small cell lung cancer (NSCLC), emphasizing its importance in identifying actionable mutations and guiding personalized treatment ...

Panelists discuss decision-making in metastatic non–-small cell lung cancer (NSCLC) when molecular testing results are delayed, focusing on strategies to optimize treatment while awaiting results.

Advanced Ovarian Cancer Pipeline Insights LAS VEGAS, NV, UNITED STATES, February 12, 2025 /EINPresswire / -- As per DelveInsight's assessme ...

Nuvation Bio Inc., a pharmaceutical company focused on cancer treatment with a market capitalization of $769 million, announced the departure of Dr. Jerry Wang, CEO of subsidiary AnHeart Therapeutics, ...

Health Canada has approved MSD's anti-programmed cell death protein 1 (PD-1) therapy Keytruda for treating adults with ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance” or the "Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ...